Journal
JOURNAL OF MEDICAL VIROLOGY
Volume 94, Issue 1, Pages 131-140Publisher
WILEY
DOI: 10.1002/jmv.27275
Keywords
COVID-19; IgG; neutrophil-to-lymphocyte ratio; nomogram; prediction
Categories
Funding
- Renmin Hospital of Wuhan University - Fundamental Research Funds for the Central Universities, China [2042020kfxg07]
Ask authors/readers for more resources
This study developed two nomogram models for distinguishing disease severity and predicting prognosis in COVID-19 patients. The results indicate that immune response phenotyping based on blood indicators can effectively identify high-risk clinical cases.
Introduction The coronavirus disease 2019 (COVID-19) has quickly become a global threat to public health, and it is difficult to predict severe patients and their prognosis. Here, we intended developing effective models for the late identification of patients at disease progression and outcome. Methods A total of 197 patients were included with a 20-day median follow-up time. We first developed a nomogram for disease severity discrimination, then created a prognostic nomogram for severe patients. Results In total, 40.6% of patients were severe and 59.4% were non-severe. The multivariate logistic analysis indicated that IgG, neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase, platelet, albumin, and blood urea nitrogen were significant factors associated with the severity of COVID-19. Using immune response phenotyping based on NLR and IgG level, the logistic model showed patients with the NLR(hi)IgG(hi) phenotype are most likely to have severe disease, especially compared to those with the NLR(lo)IgG(lo) phenotype. The C-indices of the two discriminative nomograms were 0.86 and 0.87, respectively, which indicated sufficient discriminative power. As for predicting clinical outcomes for severe patients, IgG, NLR, age, lactate dehydrogenase, platelet, monocytes, and procalcitonin were significant predictors. The prognosis of severe patients with the NLR(hi)IgG(hi) phenotype was significantly worse than the NLR(lo)IgG(hi) group. The two prognostic nomograms also showed good performance in estimating the risk of progression. Conclusions The present nomogram models are useful to identify COVID-19 patients with disease progression based on individual characteristics and immune response-related indicators. Patients at high risk for severe illness and poor outcomes from COVID-19 should be managed with intensive supportive care and appropriate therapeutic strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available